Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase

Nutrition and Cancer

Volumn 59, Issue 2, 2007, Pages 258-268

  Thangasamy, Thilakavathy ^a   Sittadjody, Sivanandane ^a   Lanza Jacoby, Susan ^b   Wachsberger, Phyllis R ^b   Limesand, Kirsten H ^a   Burd, Randy ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; MONOPHENOL MONOOXYGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; OXIDOREDUCTASE; QUERCETIN; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CELL DEATH; CELL FREE SYSTEM; CELL VIABILITY; CONTROLLED STUDY; DRUG SELECTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

EID: 36849000866     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701499545     Document Type: Article

References (32)

1. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, et al.: Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155, 381-386, 1995.
2. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, et al.: Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53, 1649-1657, 1997.
3. Pietta PG: Flavonoids as antioxidants. J Nat Prod 63, 1035-1042, 2000.
4. Murota K and Terao J: Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417, 12-17, 2003.
5. Awad HM, Boersma MG, Vervoort J, and Rietjens IM: Peroxidase-catalyzed formation of quercetin quinone methide-glutathione adducts. Arch Biochem Biophys 378, 224-233, 2000.
6. Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, and Segura-Aguilar J: Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26, 107-116, 1999.
7. Drexler I, Antunes E, Schmitz M, Wolfel T, Huber C, et al.: Modified vaccinia virus Ankara for delivery of human tyrosinase as melanomaassociated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo. Cancer Res 59, 4955-4963, 1999.
8. Bolton JL, Pisha E, Zhang F, and Qiu S: Role of quinoids in estrogen carcinogenesis. Chem Res Toxicol 11, 1113-1127, 1998.
9. Penning TM, Burczynski ME, Hung CF, McCoull KD, Palackal NT, et al.: Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem Res Toxicol 12, 1-18, 1999.
10. Awad HM, Boersma MG, Boeren S, van der WH, van ZJ, et al.: Identification of o-quinone/quinone methide metabolites of quercetin in a cellular in vitro system. FEBS Lett 520, 30-34, 2002.
11. Riley PA, Cooksey CJ, Johnson CI, Land EJ, Latter AM, et al.: Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system. Eur J Cancer 33, 135-143, 1997.
12. Ferraresi R, Troiano L, Roat E, Lugli E, Nemes E, et al.: Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic Res 39, 1249-1258, 2005.
13. Valerio LG Jr, Kepa JK, Pickwell GV, and Quattrochi LC: Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin. Toxicol Lett 119, 49-57, 2001.
14. Boots AW, Balk JM, Bast A, and Haenen GR: The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin-induced toxicity. Biochem Biophys Res Commun 338, 923-929, 2005.
15. Asher G, Lotem J, Kama R, Sachs L, and Shaul Y: NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A 99, 3099-3104, 2002.
16. Simonova M, Wall A, Weissleder R, and Bogdanov A Jr: Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cells. Cancer Res 60, 6656-6662, 2000.
17. Kubo I, Nihei K, and Shimizu K: Oxidation products of quercetin catalyzed by mushroom tyrosinase. Bioorg Med Chem 12, 5343-5347, 2004.
18. van Zanden JJ, Ben HO, van Iersel ML, Boeren S, Cnubben NH, et al.: Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin. Chem Biol Interact 145, 139-148, 2003.
19. Biaglow JE, Donahue J, Tuttle S, Held K, Chrestensen C, et al.: A method for measuring disulfide reduction by cultured mammalian cells: relative contributions of glutathione-dependent and glutathione-independent mechanisms. Anal Biochem 281, 77-86, 2000.
20. Takeda A, Matsunaga J, Tomita Y, Tagami H, and Shibahara S: Molecular analysis of the DNA segments cross-hybridizable to the tyrosinase gene in patients affected with oculocutaneous albinism. Tohoku J Exp Med 159, 333-340, 1989.
21. Biaglow JE, Ayene IS, Koch CJ, Donahue J, Stamato TD, et al.: Radiation response of cells during altered protein thiol redox. Radiat Res 159, 484-494, 2003.
22. Stark AA and Glass GA: Role of copper and ceruloplasmin in oxidative mutagenesis induced by the glutathione-gamma-glutamyl transpeptidase system and by other thiols. Environ Mol Mutagen 29, 63-72, 1997.
23. Boots AW, Kubben N, Haenen GR, and Bast A: Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem Biophys Res Commun 308, 560-565, 2003.
24. Kirkland RA, Windelborn JA, Kasprzak JM, and Franklin JL: A Bax-induced pro-oxidant state is critical for cytochrome c release during programmed neuronal death. J Neurosci 22, 6480-6490, 2002.
25. Boersma MG, Vervoort J, Szymusiak H, Lemanska K, Tyrakowska B, et al.: Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide. Chem Res Toxicol 13, 185-191, 2000.
26. Van der WH, Boersma MG, Alink GM, Vervoot J, and Rietjens IM: Consequences of quercetin methylation for its covalent glutathione and DNA adduct formation. Chem Biol Interact 160, 193-203, 2006.
27. Dal Monte M, Cerconi I, Buono F, Vilardo PG, Del Corsd A, et al.: Thioltransferase activity of bovine lens glutathione S-transferase. Biochem J 334, 57-62, 1998.
28. Guan X, Hoffman BN, McFarland DC, Gilkerson KK, Dwivedi C, et al.: Glutathione and mercapturic acid conjugates of sulofenur and their activity against a human colon cancer cell line. Drug Metab Dispos 30, 331-335, 2002.
29. Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, et al.: Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene) selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res 61, 3647-3652, 2001.
30. Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, et al.: Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-Binding protein 1). Cancer Res 67, 4382-4389, 2007.
31. Kurata M, Suzuki M, and Takeda K: Effects of phenol compounds, glutathione analogues and a diuretic drug on glutathione S-transferase, glutathione reductase and glutathione peroxidase from canine erythrocytes. Comp Biochem Physiol B 103, 863-867, 1992.
32. MacGregor JT and Jurd L: Mutagenicity of plant flavonoids: structural requirements for mutagenic activity in Salmonella typhimurium. Mutat Res 54, 297-309, 1978.